(PharmaNewsWire.Com, October 18, 2017 ) The Middle-East and Africa Cervical Cancer Diagnostics and Therapeutics market has been estimated at USD 247.80 Million in 2016 and is projected to reach USD 305.20 Million by 2021, at a CAGR of 4.25% during the forecast period from 2016 to 2021. Cervical cancers and cervical pre-cancers are classified by how they look under a microscope. The main types of cervical cancers are squamous cell carcinoma and adenocarcinoma. Cervical pre-cancers are diagnosed far more often than invasive cervical cancer. The first step in finding cervical cancer is often an abnormal Pap test result. This will lead to further tests which can diagnose cervical cancer.
The main market drivers of Middle-East and Africa Cervical Cancer Diagnostics and Therapeutics market are increasing prevalence of human papillomavirus infected patients, and increasing awareness of cervical cancer screening programs. But, factors like high costs of diagnosis tests and changes in regulatory guidelines for cervical cancer screening, are constraining the market growth.
Middle-East and Africa market for Cervical Cancer Diagnostics and Therapeutics is segmented based on diagnostics test, methods, end-users and therapies. By Diagnostics test, the market is further sub-segmented into Pap smear test, HPV testing, colposcopy, cervical cancer biopsy. By methods, the market is further sub-segmented into molecular method, cytopathological method, and physical method. By therapies, the market is further sub-segmented into surgery, radiation therapy, chemotherapy and others. By end-users, the market is further sub-segmented into hospitals, laboratories, independent physicians, clinics, and others. Pap smear test segment dominated the market by Diagnostic test, holding a 45% share in the global market for cervical cancer diagnostic tests. The high growth rate of this segment can be attributed to the high efficiency of the test, low cost of the test in comparison with other tests available in the market, and rising awareness regarding cancer diagnosis.
Geographically, Middle-East and Africa market for Cervical Cancer Diagnostics and Therapeutics is segmented into Middle-East region and Africa region. A number of factors such as rising prevalence of cervical cancer, growing awareness of cervical cancer screening programs, and government support are driving the growth of the HPV testing market in the Middle-East and African region.
Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, Volition Rx, are the major players of Middle-East and Africa Cervical Cancer Diagnostics and Therapeutics market.
Market Segmentation
1) By diagnostics test Pap smear test HPV testing Colposcopy Cervical cancer biopsy
Reasons to buy Middle East and Africa Cervical Cancer Diagnostics and Therapeutics Market Research Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
